Blumel; Claudia

Patent Applications and Registrations

Patent applications and USPTO patent grants for Blumel; Claudia.The latest application filed is for "antibody constructs for dll3 and cd3".

Company Profile

0.9.18

Blumel; Claudia - Munich DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibody constructs for FLT3 and CD3 Grant 11,447,567 - Raum , et al. September 20, 2	2022-09-20
Antibody Constructs For Dll3 And Cd3 App 20210309743 - Raum; Tobias ; et al.	2021-10-07
Antibody Constructs For Cd70 And Cd3 App 20210284748 - Raum; Tobias ; et al.	2021-09-16
Bispecific antibody constructs for CDH3 and CD3 Grant 11,028,171 - Weiss , et al. June 8, 2	2021-06-08
Bispecific Antibody Construct Directed to MUC17 and CD3 App 20210130465 - Raum; Tobias ; et al.	2021-05-06
Antibody constructs for CD70 and CD3 Grant 10,851,170 - Raum , et al. December 1, 2	2020-12-01
Cross-species-specific Pscaxcd3, Cd19xcd3, C-metxcd3, Endosialinxcd3, Epcamxcd3, Igf-1rxcd3 Or Fapalphaxcd3 Bispecific Single Chain Antibody App 20200362039 - Kufer; Peter ; et al.	2020-11-19
Antibody Constructs For Dll3 And Cd3 App 20200332002 - Raum; Tobias ; et al.	2020-10-22
Antibody constructs for DLL3 and CD3 Grant 10,683,351 - Raum , et al.	2020-06-16
Antibody Constructs for CLDN18.2 and CD3 App 20200055932 - Dahlhoff; Christoph ; et al.	2020-02-20
Antibody Constructs For Dll3 And Cd3 App 20190263907 - Raum; Tobias ; et al.	2019-08-29
Antibody constructs for DLL3 and CD3 Grant 10,294,300 - Raum , et al.	2019-05-21
Bispecific Single Chain Antibodies With Specificity For High Molecular Weight Target Antigens App 20190040133 - Kufer; Peter ; et al.	2019-02-07
Bispecific single chain antibodies with specificity for high molecular weight target antigens Grant 10,047,159 - Kufer , et al. August 14, 2	2018-08-14
Bispecific Antibody Constructs For Cdh3 And Cd3 App 20180142021 - Weiss; Bertram ; et al.	2018-05-24
Antibody Constructs For CDH19 and CD3 App 20180002450 - Xiao; Shouhua ; et al.	2018-01-04
Antibody constructs for CDH19 and CD3 Grant 9,765,157 - Xiao , et al. September 19, 2	2017-09-19
Antibody Constructs For Cd70 And Cd3 App 20170129961 - Raum; Tobias ; et al.	2017-05-11
Antibody Constructs For Dll3 And Cd3 App 20170037130 - Raum; Tobias ; et al.	2017-02-09
Antibody Constructs For Flt3 And Cd3 App 20170037149 - Raum; Tobias ; et al.	2017-02-09
Antibody Constructs For Msln And Cd3 App 20170029502 - Raum; Tobias ; et al.	2017-02-02
Bispecific Single Chain Antibodies With Specificity For High Molecular Weight Target Antigens App 20160264671 - Kufer; Peter ; et al.	2016-09-15
Bispecific single chain antibodies with specificity for high molecular weight target antigens Grant 9,260,522 - Kufer , et al. February 16, 2	2016-02-16
Antibody constructs for CDH19 and CD3 App 20160032019 - Xiao; Shouhua ; et al.	2016-02-04
CROSS-SPECIES-SPECIFIC PSCAxCD3, CD19xCD3, C-METxCD3, ENDOSIALINxCD3, EPCAMxCD3, IGF-1RxCD3 OR FAPALPHAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY App 20120034228 - Kufer; Peter ; et al.	2012-02-09
Bispecific Single Chain Antibodies With Specificity For High Molecular Weight Target Antigens App 20110262439 - Kufer; Peter ; et al.	2011-10-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.